Amoxapine

Generic name: Pronounced as (a mox' a peen)
Brand names
  • Asendin®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 09/15/2018

A small number of children, teenagers, and young adults (up to 24 years of age) who took antidepressants ('mood elevators') such as amoxapine during clinical studies became suicidal (thinking about harming or killing oneself or planning or trying to do so). Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions. However, experts are not sure about how great this risk is and how much it should be considered in deciding whether a child or teenager should take an antidepressant. Children younger than 18 years of age should not normally take amoxapine, but in some cases, a doctor may decide that amoxapine is the best medication to treat a child's condition.

You should know that your mental health may change in unexpected ways when you take amoxapine or other antidepressants even if you are an adult over age 24. You may become suicidal, especially at the beginning of your treatment and any time that your dose is increased or decreased. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: new or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor when you are unable to seek treatment on your own.

Your healthcare provider will want to see you often while you are taking amoxapine, especially at the beginning of your treatment. Be sure to keep all appointments for office visits with your doctor.

The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with amoxapine. Read the information carefully and ask your doctor or pharmacist if you have any questions. You also can obtain the Medication Guide from the FDA website: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/UCM096273.

No matter your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments. You should also talk about the risks and benefits of not treating your condition. You should know that having depression or another mental illness greatly increases the risk that you will become suicidal. This risk is higher if you or anyone in your family has or has ever had bipolar disorder (mood that changes from depressed to abnormally excited) or mania (frenzied, abnormally excited mood) or has thought about or attempted suicide. Talk to your doctor about your condition, symptoms, and personal and family medical history. You and your doctor will decide what type of treatment is right for you.

Amoxapine is used to treat depression. Amoxapine is in a class of medications called tricyclic antidepressants (TCAs). It works by increasing the amounts of certain natural substances in the brain that are needed to maintain mental balance.

Amoxapine comes as a tablet to take by mouth. It is usually taken one or more times a day. If you take amoxapine once a day, you should take it at bedtime. Try to take amoxapine at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take amoxapine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

It may take several weeks or longer for you to feel the full effect of amoxapine. Continue to take amoxapine even if you feel well. Do not stop taking amoxapine without talking to your doctor. Your doctor probably will want to decrease your dose gradually.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking amoxapine,

  • tell your doctor and pharmacist if you are allergic to amoxapine, doxepin (Sinequan), any other medications, or any of the inactive ingredients in amoxapine tablets. Ask your doctor or pharmacist for a list of the inactive ingredients.

  • tell your doctor if you are taking a monoamine oxidase (MAO) inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate), or if you have stopped taking an MAO inhibitor within the past 14 days. Your doctor will probably tell you not to take amoxapine. If you stop taking amoxapine, you should wait at least 14 days before you start to take an MAO inhibitor.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants (blood thinners) such as warfarin (Coumadin); antihistamines; cimetidine (Tagamet); flecainide (Tambocor); levodopa (Sinemet, Larodopa); lithium (Eskalith, Lithobid); medications for high blood pressure, seizures, Parkinson's disease, asthma, colds, or allergies; methylphenidate (Ritalin); muscle relaxants; propafenone (Rhythmol); quinidine; sedatives; selective serotonin reuptake inhibitors (SSRIs) such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft); sleeping pills; thyroid medications; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you more carefully for side effects.

  • tell your doctor if you are being treated with electroshock therapy (procedure in which small electric shocks are administered to the brain to treat certain mental illnesses) and if you have or have ever had a heart attack, glaucoma (an eye disease), an enlarged prostate (a male reproductive organ), difficulty urinating, seizures, an overactive thyroid gland, or liver, kidney, or heart disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking amoxapine, call your doctor immediately.

  • talk to your doctor about the risks and benefits of taking amoxapine if you are 65 years of age or older. Older adults should not usually take amoxapine because it is not as safe or effective as other medications that can be used to treat the same condition.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking amoxapine.

  • you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Amoxapine may cause side effects. Tell your doctor if any of the following symptoms are severe or do not go away:

    • nausea

    • drowsiness

    • weakness or tiredness

    • nightmares

    • dry mouth

    • skin more sensitive to sunlight than usual

    • changes in appetite or weight

    • constipation

    • difficulty urinating

    • frequent urination

    • blurred vision

    • excessive sweating

  • Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:

    • muscle stiffness

    • confusion

    • fast or irregular heartbeat

    • slow or difficult speech

    • shuffling walk

    • uncontrollable shaking or moving of a part of the body

    • fever

    • rash

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

  • Amoxapine may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • seizures

  • coma (loss of consciousness for a period of time)

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Moxifloxacin.
Repaglinide Repaglinide Amoxapine may decrease the hypoglycemic activities of Repaglinide.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection Amoxapine may decrease the hypoglycemic activities of Insulin glargine.
Delavirdine Delavirdine The metabolism of Amoxapine can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Amoxapine.
Dolasetron Dolasetron The metabolism of Amoxapine can be decreased when combined with Dolasetron.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Anagrelide.
Bisacodyl Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Amoxapine.
Candesartan Candesartan Amoxapine may decrease the antihypertensive activities of Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Amoxapine.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Amoxapine is combined with Diphenoxylate.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The serum concentration of Amoxapine can be increased when it is combined with Conjugated estrogens.
Guanfacine Guanfacine The risk or severity of hypertension can be increased when Amoxapine is combined with Guanfacine.
Magnesium Hydroxide Magnesium Hydroxide The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Amoxapine.
Magnesium Oxide Magnesium Oxide The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Amoxapine.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Amoxapine.
Miglitol Miglitol Amoxapine may decrease the hypoglycemic activities of Miglitol.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Amoxapine is combined with Naratriptan.
Olsalazine Olsalazine The risk or severity of hypertension can be increased when Amoxapine is combined with Olsalazine.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Amoxapine is combined with Morphine.
Penbutolol Penbutolol The metabolism of Acebutolol can be decreased when combined with Amoxapine.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Amoxapine is combined with Pentazocine.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Amoxapine.
Psyllium Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Amoxapine.
Ranitidine Ranitidine The metabolism of Amoxapine can be decreased when combined with Ranitidine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Amoxapine.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Amoxapine is combined with Rizatriptan.
Sumatriptan Sumatriptan Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Tacrolimus Tacrolimus The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Tacrolimus.
Tizanidine Tizanidine The risk or severity of hypertension can be increased when Amoxapine is combined with Tizanidine.
Zolmitriptan Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amoxapine.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Famotidine.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Amoxapine.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Amoxapine.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Amoxapine.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Amoxapine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of adverse effects can be increased when Metoclopramide is combined with Amoxapine.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Metronidazole.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Morphine.
Altretamine Altretamine Amphetamine may decrease the sedative and stimulatory activities of Amoxapine.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Amoxapine.
Ondansetron Ondansetron The metabolism of Amoxapine can be decreased when combined with Ondansetron.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Amoxapine is combined with Granisetron.
Torsemide Torsemide Amoxapine may decrease the antihypertensive activities of Torasemide.
Olanzapine Olanzapine Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Alosetron Alosetron The risk or severity of adverse effects can be increased when Amoxapine is combined with Alosetron.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Dofetilide.
Entacapone Entacapone The metabolism of Amoxapine can be decreased when combined with Entacapone.
Eprosartan Eprosartan Amoxapine may decrease the antihypertensive activities of Eprosartan.
Hydroxychloroquine Hydroxychloroquine The metabolism of Hydroxychloroquine can be decreased when combined with Amoxapine.
Meloxicam Meloxicam The risk or severity of hypertension can be increased when Amoxapine is combined with Meloxicam.
Oxcarbazepine Oxcarbazepine Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Telmisartan Telmisartan Amoxapine may decrease the antihypertensive activities of Telmisartan.
Zaleplon Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Anakinra Anakinra The metabolism of Amoxapine can be increased when combined with Anakinra.
Desloratadine Desloratadine Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Amoxapine.
Rivastigmine Rivastigmine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Rivastigmine.
Trimipramine Trimipramine Trimipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Etanercept Injection Etanercept Injection The metabolism of Amoxapine can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate The risk or severity of adverse effects can be increased when Amoxapine is combined with Glycopyrronium.
Perindopril Perindopril Amoxapine may decrease the antihypertensive activities of Perindopril.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of hypertension can be increased when Amoxapine is combined with Choline magnesium trisalicylate.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Amoxapine is combined with Dutasteride.
Epinephrine Injection Epinephrine Injection Amoxapine may increase the vasopressor activities of Epinephrine.
Eplerenone Eplerenone Amoxapine may decrease the antihypertensive activities of Eplerenone.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Amoxapine is combined with Escitalopram.
Olmesartan Olmesartan Amoxapine may decrease the antihypertensive activities of Olmesartan.
Zonisamide Zonisamide Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Adalimumab Injection Adalimumab Injection The metabolism of Amoxapine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Atomoxetine Atomoxetine The metabolism of Amoxapine can be decreased when combined with Atomoxetine.
Dexmethylphenidate Dexmethylphenidate The serum concentration of Amoxapine can be increased when it is combined with Dexmethylphenidate.
Atazanavir Atazanavir The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Amoxapine can be decreased when combined with Almotriptan.
Eletriptan Eletriptan The metabolism of Amoxapine can be decreased when combined with Eletriptan.
Mefloquine Mefloquine The metabolism of Amoxapine can be decreased when combined with Mefloquine.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Amoxapine.
Vardenafil Vardenafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Vardenafil is combined with Amoxapine.
Alfuzosin Alfuzosin Alfuzosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Memantine Memantine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Memantine.
Tegaserod Tegaserod The metabolism of Amoxapine can be decreased when combined with Tegaserod.
Tadalafil Tadalafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Tadalafil is combined with Amoxapine.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Amoxapine is combined with Frovatriptan.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Amoxapine.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Apomorphine.
Infliximab Injection Infliximab Injection The metabolism of Amoxapine can be increased when combined with Infliximab.
Protriptyline Protriptyline The metabolism of Amoxapine can be decreased when combined with Protriptyline.
Duloxetine Duloxetine The metabolism of Amoxapine can be decreased when combined with Duloxetine.
Trospium Trospium The metabolism of Trospium can be decreased when combined with Amoxapine.
Bosentan Bosentan Amoxapine may decrease the antihypertensive activities of Bosentan.
Cinacalcet Cinacalcet The metabolism of Amoxapine can be decreased when combined with Cinacalcet.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Amoxapine.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Amoxapine is combined with Eszopiclone.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection Amoxapine may decrease the hypoglycemic activities of Insulin aspart.
Solifenacin Solifenacin The metabolism of Solifenacin can be decreased when combined with Amoxapine.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Voriconazole.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the sedative and stimulatory activities of Amoxapine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Amoxapine can be decreased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Amoxapine.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Exenatide Injection Exenatide Injection Amoxapine may decrease the hypoglycemic activities of Exenatide.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ibandronate.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Amoxapine is combined with Isocarboxazid.
Ramelteon Ramelteon Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Darifenacin Darifenacin The metabolism of Amoxapine can be decreased when combined with Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Amoxapine is combined with Fentanyl.
Pregabalin Pregabalin The therapeutic efficacy of Amoxapine can be increased when used in combination with Pregabalin.
Phenylephrine Phenylephrine Amoxapine may increase the vasopressor activities of Phenylephrine.
Tipranavir Tipranavir The metabolism of Amoxapine can be decreased when combined with Tipranavir.
Felbamate Felbamate Felbamate may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection Amoxapine may decrease the hypoglycemic activities of Insulin detemir.
Ranolazine Ranolazine The serum concentration of Amoxapine can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Amoxapine can be increased when combined with Abatacept.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Rasagiline is combined with Amoxapine.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Amoxapine.
Sitagliptin Sitagliptin Amoxapine may decrease the hypoglycemic activities of Sitagliptin.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Amoxapine.
Albuterol Albuterol The risk or severity of hypertension can be increased when Amoxapine is combined with Salbutamol.
Paliperidone Paliperidone Paliperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Bortezomib Bortezomib The metabolism of Amoxapine can be decreased when combined with Bortezomib.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection Amoxapine may decrease the hypoglycemic activities of Insulin glulisine.
Lubiprostone Lubiprostone The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Amoxapine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Oxaliplatin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Posaconazole.
Primaquine Primaquine The metabolism of Amoxapine can be decreased when combined with Primaquine.
Aliskiren Aliskiren Amoxapine may decrease the antihypertensive activities of Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate Amoxapine may increase the neurotoxic activities of Bismuth subsalicylate.
Dimenhydrinate Dimenhydrinate Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Lisdexamfetamine Lisdexamfetamine Lisdexamfetamine may decrease the sedative and stimulatory activities of Amoxapine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Amoxapine can be decreased when combined with Sorafenib.
Sunitinib Sunitinib Amoxapine may decrease the hypoglycemic activities of Sunitinib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Lapatinib.
Levocetirizine Levocetirizine Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Dasatinib Dasatinib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Amoxapine.
Paclitaxel (with polyoxyethylated castor oil) Injection Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Amoxapine.
Temsirolimus Temsirolimus The metabolism of Amoxapine can be decreased when combined with Temsirolimus.
Nilotinib Nilotinib The metabolism of Amoxapine can be decreased when combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Toremifene.
Desmopressin Desmopressin The risk or severity of hyponatremia and water intoxication can be increased when Amoxapine is combined with Desmopressin.
Betaine Betaine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Glycine betaine.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Botulinum toxin type A.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Botulinum Toxin Type B.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine The metabolism of Desvenlafaxine can be decreased when combined with Amoxapine.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Amoxapine.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Amoxapine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Amoxapine.
Certolizumab Injection Certolizumab Injection The metabolism of Amoxapine can be increased when combined with Certolizumab pegol.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Amoxapine.
Silodosin Silodosin Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Silodosin.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Amoxapine is combined with Midazolam.
Naltrexone Injection Naltrexone Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Naltrexone.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Amoxapine is combined with Milnacipran.
Sodium Phosphate Sodium Phosphate The risk or severity of seizure can be increased when Amoxapine is combined with Sodium phosphate, monobasic.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Amoxapine.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Degarelix.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Amoxapine.
Iloperidone Iloperidone Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Lacosamide Lacosamide Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Everolimus Everolimus The metabolism of Amoxapine can be decreased when combined with Everolimus.
Dronedarone Dronedarone Dronedarone may increase the QTc-prolonging activities of Amoxapine.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Botulinum toxin type A.
Palonosetron Injection Palonosetron Injection The metabolism of Amoxapine can be decreased when combined with Palonosetron.
Saxagliptin Saxagliptin Amoxapine may decrease the hypoglycemic activities of Saxagliptin.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Romidepsin.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Golimumab Injection Golimumab Injection The metabolism of Amoxapine can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Amoxapine.
Asenapine Asenapine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.
Vigabatrin Vigabatrin Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Amoxapine.
Liraglutide Injection Liraglutide Injection Amoxapine may decrease the hypoglycemic activities of Liraglutide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Amoxapine can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine The risk or severity of seizure can be increased when Amoxapine is combined with Dalfampridine.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Eribulin.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Botulinum toxin type A.
Lurasidone Lurasidone Amoxapine may increase the hypotensive activities of Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Amoxapine.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Amoxapine.
Terbutaline Injection Terbutaline Injection The therapeutic efficacy of Amoxapine can be decreased when used in combination with Terbutaline.
Linagliptin Linagliptin Amoxapine may decrease the hypoglycemic activities of Linagliptin.
Rilpivirine Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Amoxapine.
Potassium Iodide Potassium Iodide The risk or severity of Cardiac Arrhythmia can be increased when Potassium Iodide is combined with Amoxapine.
Cyclophosphamide Injection Cyclophosphamide Injection Cyclophosphamide may increase the neurotoxic activities of Amoxapine.
Abiraterone Abiraterone The metabolism of Amoxapine can be decreased when combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Triptorelin.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Vandetanib.
Clobazam Clobazam The metabolism of Amoxapine can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Amoxapine.
Crizotinib Crizotinib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Crizotinib.
Cabergoline Cabergoline Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Ambrisentan Ambrisentan Amoxapine may decrease the antihypertensive activities of Ambrisentan.
Ezogabine Ezogabine Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Mirabegron Mirabegron The risk or severity of urinary retention can be increased when Amoxapine is combined with Mirabegron.
Linaclotide Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Amoxapine.
Lorcaserin Lorcaserin Amoxapine may decrease the hypoglycemic activities of Mecasermin.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Bedaquiline.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Amoxapine.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Amoxapine.
Pomalidomide Pomalidomide Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Canagliflozin Canagliflozin Amoxapine may decrease the hypoglycemic activities of Canagliflozin.
Dabrafenib Dabrafenib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Amoxapine can be decreased when combined with Ospemifene.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Amoxapine.
Vortioxetine Vortioxetine The metabolism of Amoxapine can be decreased when combined with Vortioxetine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Amoxapine.
Avanafil Avanafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Avanafil is combined with Amoxapine.
Ketorolac Injection Ketorolac Injection The risk or severity of hypertension can be increased when Ketorolac is combined with Amoxapine.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Amoxapine.
Apremilast Apremilast The metabolism of Amoxapine can be increased when combined with Apremilast.
Droxidopa Droxidopa Amoxapine may increase the vasopressor activities of Droxidopa.
Ceritinib Ceritinib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Amoxapine can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection Amoxapine may decrease the hypoglycemic activities of Albiglutide.
Eslicarbazepine Eslicarbazepine Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Oritavancin Injection Oritavancin Injection The metabolism of Amoxapine can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin Amoxapine may decrease the hypoglycemic activities of Empagliflozin.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Suvorexant Suvorexant Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection Amoxapine may decrease the hypoglycemic activities of Dulaglutide.
Methamphetamine Methamphetamine Metamfetamine may decrease the sedative and stimulatory activities of Amoxapine.
Tasimelteon Tasimelteon Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Riociguat Riociguat Amoxapine may decrease the antihypertensive activities of Riociguat.
Secukinumab Injection Secukinumab Injection The metabolism of Amoxapine can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Insulin Human Inhalation Insulin Human Inhalation Amoxapine may decrease the hypoglycemic activities of Insulin human.
Lenvatinib Lenvatinib The metabolism of Lenvatinib can be decreased when combined with Amoxapine.
Naloxegol Naloxegol The metabolism of Amoxapine can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Amoxapine can be decreased when combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The serum concentration of Amoxapine can be increased when it is combined with Haloperidol.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ivabradine.
Macitentan Macitentan Amoxapine may decrease the antihypertensive activities of Macitentan.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Amoxapine is combined with Flibanserin.
Rolapitant Rolapitant The metabolism of Amoxapine can be decreased when combined with Rolapitant.
Brexpiprazole Brexpiprazole Brexpiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amoxapine.
Cariprazine Cariprazine The metabolism of Amoxapine can be decreased when combined with Cariprazine.
Eluxadoline Eluxadoline The risk or severity of constipation can be increased when Amoxapine is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection Amoxapine may decrease the hypoglycemic activities of Insulin degludec.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Amoxapine.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Cobicistat Cobicistat The metabolism of Amoxapine can be decreased when combined with Cobicistat.
Midodrine Midodrine Midodrine may increase the vasopressor activities of Amoxapine.
Selexipag Selexipag Amoxapine may decrease the antihypertensive activities of Selexipag.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Amoxapine is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Amoxapine.
Furosemide Injection Furosemide Injection Amoxapine may decrease the antihypertensive activities of Furosemide.
Rucaparib Rucaparib The metabolism of Amoxapine can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Amoxapine may decrease the hypoglycemic activities of Lixisenatide.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ribociclib.
Doxepin (Insomnia) Doxepin (Insomnia) Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxepin.
Plecanatide Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Amoxapine.
Deutetrabenazine Deutetrabenazine The risk or severity of adverse effects can be increased when Amoxapine is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Amoxapine.
Safinamide Safinamide The metabolism of Amoxapine can be decreased when combined with Safinamide.
Midostaurin Midostaurin The metabolism of Amoxapine can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Amoxapine.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Delafloxacin.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Amoxapine.
Semaglutide Injection Semaglutide Injection Amoxapine may decrease the hypoglycemic activities of Semaglutide.
Tetrabenazine Tetrabenazine The risk or severity of adverse effects can be increased when Amoxapine is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Amoxapine may decrease the hypoglycemic activities of Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Fostamatinib Fostamatinib The risk or severity of hypotension, dyspepsia, and headache can be increased when Fostamatinib is combined with Amoxapine.
Lofexidine Lofexidine The therapeutic efficacy of Amoxapine can be increased when used in combination with Lofexidine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Amoxapine.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Amoxapine.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Amoxapine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Amoxapine.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amoxapine.
Dacomitinib Dacomitinib The metabolism of Amoxapine can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The metabolism of Amoxapine can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Amoxapine can be decreased when used in combination with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Glasdegib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection Amoxapine may increase the neurotoxic activities of Paclitaxel.
Rifamycin Rifamycin The metabolism of Amoxapine can be decreased when combined with Rifamycin.
Prucalopride Prucalopride The therapeutic efficacy of Prucalopride can be decreased when used in combination with Amoxapine.
Magnesium Citrate Magnesium Citrate The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Amoxapine.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Amoxapine can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of hypertension can be increased when Amoxapine is combined with Siponimod.
Brexanolone Injection Brexanolone Injection Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Amoxapine.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Amoxapine.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Amoxapine.
Pitolisant Pitolisant The therapeutic efficacy of Pitolisant can be decreased when used in combination with Amoxapine.
Fedratinib Fedratinib The metabolism of Amoxapine can be decreased when combined with Fedratinib.
Lefamulin Lefamulin Amoxapine may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Amoxapine can be decreased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Lumateperone Lumateperone Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Amoxapine is combined with Lasmiditan.
Cenobamate Cenobamate The therapeutic efficacy of Cenobamate can be decreased when used in combination with Amoxapine.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Amoxapine is combined with Selpercatinib.
Lemborexant Lemborexant Lemborexant may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Amoxapine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Fostemsavir.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Amoxapine.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Amoxapine is combined with Naxitamab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Relugolix.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Amoxapine is combined with Viloxazine.
Theophylline Theophylline The metabolism of Amoxapine can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen The risk or severity of hypertension can be increased when Amoxapine is combined with Fenoprofen.
Indomethacin Indomethacin The risk or severity of hypertension can be increased when Indomethacin is combined with Amoxapine.
Mefenamic Acid Mefenamic Acid The risk or severity of hypertension can be increased when Amoxapine is combined with Mefenamic acid.
Naproxen Naproxen The risk or severity of hypertension can be increased when Amoxapine is combined with Naproxen.
Tolmetin Tolmetin The risk or severity of hypertension can be increased when Tolmetin is combined with Amoxapine.
Sulindac Sulindac The risk or severity of hypertension can be increased when Amoxapine is combined with Sulindac.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Amoxapine.
Hydroxyurea Hydroxyurea The metabolism of Amoxapine can be decreased when combined with Hydroxyurea.
Phenobarbital Phenobarbital Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Amoxapine is combined with Metaxalone.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Amoxapine is combined with Levorphanol.
Primidone Primidone The metabolism of Amoxapine can be increased when combined with Primidone.
Methsuximide Methsuximide Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Diethylpropion Diethylpropion Diethylpropion may decrease the sedative and stimulatory activities of Amoxapine.
Chlorpromazine Chlorpromazine Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Amoxapine is combined with Diazepam.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Amoxapine is combined with Oxazepam.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Amoxapine is combined with Flurazepam.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Amoxapine is combined with Clorazepic acid.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Amoxapine.
Phenoxybenzamine Phenoxybenzamine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.
Amantadine Amantadine The risk or severity of serotonin syndrome can be increased when Amoxapine is combined with Amantadine.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Amoxapine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Amoxapine.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Amoxapine.
Bromocriptine Bromocriptine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypertension can be increased when Amoxapine is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The metabolism of Tranylcypromine can be decreased when combined with Amoxapine.
Phenelzine Phenelzine The metabolism of Amoxapine can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Amoxapine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Amoxapine is combined with Ergoloid mesylate.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Prochlorperazine Prochlorperazine The serum concentration of Amoxapine can be increased when it is combined with Prochlorperazine.
Thioridazine Thioridazine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Thioridazine.
Trifluoperazine Trifluoperazine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Trifluoperazine.
Sulfadiazine Sulfadiazine Amoxapine may decrease the hypoglycemic activities of Sulfadiazine.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Amoxapine.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Amoxapine.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Amoxapine.
Benztropine Benztropine The risk or severity of adverse effects can be increased when Amoxapine is combined with Benzatropine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Amoxapine.
Ibuprofen Ibuprofen The risk or severity of hypertension can be increased when Amoxapine is combined with Ibuprofen.
Trihexyphenidyl Trihexyphenidyl Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The serum concentration of Perphenazine can be increased when it is combined with Amoxapine.
Fluphenazine Fluphenazine The serum concentration of Fluphenazine can be increased when it is combined with Amoxapine.
Phentermine Phentermine Phentermine may decrease the sedative and stimulatory activities of Amoxapine.
Methylphenidate Methylphenidate The risk or severity of adverse effects can be increased when Amoxapine is combined with Methylphenidate.
Sulfasalazine Sulfasalazine The risk or severity of hypertension can be increased when Amoxapine is combined with Sulfasalazine.
Doxorubicin Doxorubicin The metabolism of Amoxapine can be decreased when combined with Doxorubicin.
Mechlorethamine Mechlorethamine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Mechlorethamine.
Pyridostigmine Pyridostigmine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Pyridostigmine.
Carbamazepine Carbamazepine Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Molindone Molindone The risk or severity of adverse effects can be increased when Amoxapine is combined with Molindone.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Amoxapine.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Amoxapine.
Prazosin Prazosin Prazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Hydralazine Hydralazine Amoxapine may decrease the antihypertensive activities of Hydralazine.
Cimetidine Cimetidine The metabolism of Amoxapine can be decreased when combined with Cimetidine.
Warfarin Warfarin The risk or severity of adverse effects can be increased when Amoxapine is combined with Warfarin.
Clonazepam Clonazepam Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Amoxapine.
Promethazine Promethazine The serum concentration of Amoxapine can be increased when it is combined with Promethazine.
Meclofenamate Meclofenamate The risk or severity of hypertension can be increased when Amoxapine is combined with Meclofenamic acid.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Amoxapine.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Amoxapine.
Chloroquine Chloroquine The metabolism of Amoxapine can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Amoxapine can be decreased when combined with Quinine.
Ethosuximide Ethosuximide Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Amoxapine.
Chlorothiazide Chlorothiazide The serum concentration of Chlorothiazide can be increased when it is combined with Amoxapine.
Chlorthalidone Chlorthalidone The serum concentration of Chlorthalidone can be increased when it is combined with Amoxapine.
Metolazone Metolazone The serum concentration of Metolazone can be increased when it is combined with Amoxapine.
Clindamycin Injection Clindamycin Injection Amoxapine may increase the neurotoxic activities of Clindamycin.
Secobarbital Secobarbital The metabolism of Amoxapine can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Amoxapine.
Amitriptyline Amitriptyline Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Imipramine Imipramine Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Quinidine Quinidine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Amoxapine.
Isoniazid Isoniazid The risk or severity of serotonin syndrome can be increased when Amoxapine is combined with Isoniazid.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Amoxapine.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Amoxapine.
Butabarbital Butabarbital Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Levothyroxine Levothyroxine The risk or severity of Cardiac Arrhythmia and CNS stimulation can be increased when Levothyroxine is combined with Amoxapine.
Liothyronine Liothyronine The risk or severity of Cardiac Arrhythmia can be increased when Liothyronine is combined with Amoxapine.
Methimazole Methimazole The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Amoxapine.
Propylthiouracil Propylthiouracil The risk or severity of Cardiac Arrhythmia can be increased when Propylthiouracil is combined with Amoxapine.
Chlorpropamide Chlorpropamide Amoxapine may decrease the hypoglycemic activities of Chlorpropamide.
Glucagon Injection Glucagon Injection Amoxapine may increase the gastrointestinal motility reducing activities of Glucagon.
Tolbutamide Tolbutamide Amoxapine may decrease the hypoglycemic activities of Tolbutamide.
Tolazamide Tolazamide Amoxapine may decrease the hypoglycemic activities of Tolazamide.
Dextromethorphan Dextromethorphan The metabolism of Amoxapine can be decreased when combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Amoxapine.
Niacin Niacin The metabolism of Amoxapine can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Amoxapine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Cyproheptadine Cyproheptadine Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Clemastine Clemastine The metabolism of Amoxapine can be decreased when combined with Clemastine.
Chlorpheniramine Chlorpheniramine The metabolism of Amoxapine can be decreased when combined with Chlorpheniramine.
Brompheniramine Brompheniramine Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Meclizine Meclizine The metabolism of Amoxapine can be decreased when combined with Meclizine.
Methyclothiazide Methyclothiazide The serum concentration of Methyclothiazide can be increased when it is combined with Amoxapine.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Hydrochlorothiazide.
Dantrolene Dantrolene Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Chlorzoxazone Chlorzoxazone The metabolism of Amoxapine can be decreased when combined with Chlorzoxazone.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Amoxapine.
Methocarbamol Methocarbamol Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Amoxapine.
Minoxidil Minoxidil Amoxapine may decrease the antihypertensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine Pseudoephedrine may decrease the sedative and stimulatory activities of Amoxapine.
Nortriptyline Nortriptyline Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Amoxapine.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Butorphanol.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Amoxapine is combined with Nalbuphine.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Amoxapine.
Trimethobenzamide Trimethobenzamide Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Flavoxate Flavoxate Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Fluorouracil.
Acetazolamide Acetazolamide Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Calcitonin Salmon Injection Calcitonin Salmon Injection The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amoxapine.
Ketoconazole Ketoconazole The metabolism of Amoxapine can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Thiotepa Injection Thiotepa Injection The therapeutic efficacy of Amoxapine can be decreased when used in combination with Thiotepa.
Vincristine Injection Vincristine Injection Vincristine may increase the neurotoxic activities of Amoxapine.
Captopril Captopril Amoxapine may decrease the antihypertensive activities of Captopril.
Dipyridamole Dipyridamole The risk or severity of hypotension, dyspepsia, and headache can be increased when Dipyridamole is combined with Amoxapine.
Isoxsuprine Isoxsuprine The risk or severity of hypertension can be increased when Amoxapine is combined with Isoxsuprine.
Vinblastine Vinblastine The metabolism of Amoxapine can be decreased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Amoxapine can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Amoxapine.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Amoxapine is combined with Thiothixene.
Aspirin Aspirin The risk or severity of hypertension can be increased when Amoxapine is combined with Acetylsalicylic acid.
Salsalate Salsalate The risk or severity of hypertension can be increased when Amoxapine is combined with Salsalate.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Amoxapine.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Amoxapine.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Amoxapine is combined with Triazolam.
Dicyclomine Dicyclomine Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Amoxapine.
Nifedipine Nifedipine The metabolism of Nifedipine can be decreased when combined with Amoxapine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Amoxapine.
Verapamil Verapamil Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.
Atenolol Atenolol The metabolism of Atenolol can be decreased when combined with Amoxapine.
Pindolol Pindolol The metabolism of Pindolol can be decreased when combined with Amoxapine.
Cisplatin Injection Cisplatin Injection The therapeutic efficacy of Amoxapine can be decreased when used in combination with Cisplatin.
Diflunisal Diflunisal The risk or severity of hypertension can be increased when Amoxapine is combined with Diflunisal.
Piroxicam Piroxicam The risk or severity of hypertension can be increased when Amoxapine is combined with Piroxicam.
Glyburide Glyburide Amoxapine may decrease the hypoglycemic activities of Glyburide.
Glipizide Glipizide Amoxapine may decrease the hypoglycemic activities of Glipizide.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Indapamide.
Pentoxifylline Pentoxifylline The risk or severity of hypotension, dyspepsia, and headache can be increased when Pentoxifylline is combined with Amoxapine.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Amoxapine.
Labetalol Labetalol Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Labetalol.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Leuprolide.
Guanabenz Guanabenz The risk or severity of hypertension can be increased when Amoxapine is combined with Guanabenz.
Ketoprofen Ketoprofen The risk or severity of hypertension can be increased when Amoxapine is combined with Ketoprofen.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Amoxapine.
Enalapril Enalapril Amoxapine may decrease the antihypertensive activities of Enalapril.
Flurbiprofen Flurbiprofen The risk or severity of hypertension can be increased when Amoxapine is combined with Flurbiprofen.
Amiodarone Amiodarone The metabolism of Amoxapine can be decreased when combined with Amiodarone.
Buspirone Buspirone The metabolism of Amoxapine can be decreased when combined with Buspirone.
Lovastatin Lovastatin The metabolism of Amoxapine can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ciprofloxacin.
Mesalamine Mesalamine The risk or severity of hypertension can be increased when Mesalazine is combined with Amoxapine.
Diclofenac Diclofenac The risk or severity of hypertension can be increased when Amoxapine is combined with Diclofenac.
Fluoxetine Fluoxetine The serum concentration of Amoxapine can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Nimodipine.
Clozapine Clozapine Clozapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Amoxapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Amoxapine is combined with Estazolam.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Amoxapine.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ofloxacin.
Didanosine Didanosine Amoxapine may increase the neurotoxic activities of Didanosine.
Clarithromycin Clarithromycin The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Clarithromycin.
Benazepril Benazepril Amoxapine may decrease the antihypertensive activities of Benazepril.
Etodolac Etodolac The risk or severity of hypertension can be increased when Amoxapine is combined with Etodolac.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Amoxapine.
Fosinopril Fosinopril Amoxapine may decrease the antihypertensive activities of Fosinopril.
Nabumetone Nabumetone The risk or severity of hypertension can be increased when Nabumetone is combined with Amoxapine.
Quinapril Quinapril Amoxapine may decrease the antihypertensive activities of Quinapril.
Ramipril Ramipril Amoxapine may decrease the antihypertensive activities of Ramipril.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Amoxapine.
Amlodipine Amlodipine The risk or severity of hypotension can be increased when Amoxapine is combined with Amlodipine.
Teniposide Injection Teniposide Injection Teniposide may increase the neurotoxic activities of Amoxapine.
Itraconazole Itraconazole The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Itraconazole.
Lisinopril Lisinopril Amoxapine may decrease the antihypertensive activities of Lisinopril.
Oxaprozin Oxaprozin The risk or severity of hypertension can be increased when Amoxapine is combined with Oxaprozin.
Sotalol Sotalol The metabolism of Amoxapine can be decreased when combined with Sotalol.
Bisoprolol Bisoprolol Bisoprolol may increase the orthostatic hypotensive activities of Amoxapine.
Zolpidem Zolpidem Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.
Terazosin Terazosin Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Terazosin.
Isradipine Isradipine The risk or severity of hypotension can be increased when Amoxapine is combined with Isradipine.
Omeprazole Omeprazole The metabolism of Amoxapine can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Amoxapine can be decreased when combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Amoxapine is combined with Gabapentin.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Amoxapine.
Venlafaxine Venlafaxine The metabolism of Amoxapine can be decreased when combined with Venlafaxine.
Nizatidine Nizatidine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Nizatidine.
Stavudine Stavudine Amoxapine may increase the neurotoxic activities of Stavudine.
Fluvoxamine Fluvoxamine The metabolism of Amoxapine can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nefazodone.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Amoxapine is combined with Lamotrigine.
Losartan Losartan The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Losartan.
Tramadol Tramadol The risk or severity of serotonin syndrome can be increased when Amoxapine is combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Amoxapine can be decreased when combined with Vinorelbine.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Moexipril.
Lansoprazole Lansoprazole The metabolism of Amoxapine can be decreased when combined with Lansoprazole.
Nicardipine Nicardipine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nicardipine.
Bupropion Bupropion The risk or severity of seizure can be increased when Amoxapine is combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Amoxapine can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Amoxapine.
Metformin Metformin Amoxapine may decrease the hypoglycemic activities of Metformin.
Nisoldipine Nisoldipine The risk or severity of hypotension can be increased when Amoxapine is combined with Nisoldipine.
Riluzole Riluzole Riluzole may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Acarbose Acarbose Amoxapine may decrease the hypoglycemic activities of Acarbose.
Glimepiride Glimepiride Amoxapine may decrease the hypoglycemic activities of Glimepiride.
Ritonavir Ritonavir The metabolism of Amoxapine can be decreased when combined with Ritonavir.
Clomipramine Clomipramine The metabolism of Amoxapine can be decreased when combined with Clomipramine.
Mirtazapine Mirtazapine Amoxapine may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Amoxapine may decrease the antihypertensive activities of Trandolapril.
Topiramate Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Amoxapine is combined with Topiramate.
Valsartan Valsartan Amoxapine may decrease the antihypertensive activities of Valsartan.
Insulin Lispro Injection Insulin Lispro Injection Amoxapine may decrease the hypoglycemic activities of Insulin lispro.
Pramipexole Pramipexole The therapeutic efficacy of Pramipexole can be decreased when used in combination with Amoxapine.
Donepezil Donepezil The therapeutic efficacy of Amoxapine can be decreased when used in combination with Donepezil.
Nelfinavir Nelfinavir The metabolism of Amoxapine can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Azithromycin.
Loratadine Loratadine Amoxapine may increase the anticholinergic activities of Loratadine.
Carvedilol Carvedilol Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Selegiline Selegiline The metabolism of Amoxapine can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Amoxapine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Amoxapine.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Amoxapine.
Irbesartan Irbesartan Amoxapine may decrease the antihypertensive activities of Irbesartan.
Tamsulosin Tamsulosin Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.
Ropinirole Ropinirole The therapeutic efficacy of Ropinirole can be decreased when used in combination with Amoxapine.
Finasteride Finasteride The risk or severity of hypertension can be increased when Amoxapine is combined with Finasteride.
Quetiapine Quetiapine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.
Cetirizine Cetirizine Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Amoxapine.
Tolcapone Tolcapone Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Citalopram Citalopram The metabolism of Citalopram can be decreased when combined with Amoxapine.
Efavirenz Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Amoxapine.
Sildenafil Sildenafil The metabolism of Amoxapine can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone Amoxapine may decrease the hypoglycemic activities of Pioglitazone.
Celecoxib Celecoxib The metabolism of Amoxapine can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Amoxapine.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Amoxapine.
Thalidomide Thalidomide Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Balsalazide Balsalazide The risk or severity of hypertension can be increased when Amoxapine is combined with Balsalazide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Amoxapine.
Galantamine Galantamine The metabolism of Amoxapine can be decreased when combined with Galantamine.
Levetiracetam Levetiracetam Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Rabeprazole Rabeprazole The metabolism of Amoxapine can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Amoxapine can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!